Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2022

BOSTON, July 08, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN ), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patients' lives, announced today that Manuel Aivado, M.D., Ph.D., President and Chief Executive Officer, is scheduled to participate in a fireside chat at the William Blair Biotech Focus Conference 2022, which will be available to view on-demand beginning Monday, July 11, 2022. Management will be available for in-person meetings at the conference on Tuesday, July 12, 2022. A webcast of the fireside chat will be available under the Investors and Media section of Aileron's website at https://investors.aileronrx.com . A replay of the webcast will ... Full story available on Benzinga.com